Fisetin: benefits, dosage, side effects and what the human evidence shows

Fisetin is the strongest senolytic flavonoid in lab screens. In people, the best data so far is one small trial where it lowered inflammation markers. Here is what that gap means, with the real numbers on food, dose and safety.

Reviewed by LifeFrom’s medical AIPublished November 17, 2026 · 10 min read
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    Senolytic in the lab, anti-inflammatory signal in people

    Fisetin clears senescent cells and extends lifespan in preclinical studies, but the only published human result is lower hs-CRP and IL-8 in one small trial; no human study has shown it removes senescent cells.

  2. 02
    Micrograms per gram, not per cup

    Strawberries hold about 160 micrograms of fisetin per gram, so a 150 g cup carries about 24 mg, not 0.16 mg.

  3. 03
    Dose conversion uses body surface area

    A preclinical dose of 100 mg/kg converts to about 8 mg/kg in adults, roughly 570 mg for 70 kg, not 7 g.

Fisetin earned its reputation in the lab: in a 2018 screen of 10 flavonoids it was the most potent at killing senescent cells, and late-life dosing extended median and maximum lifespan in preclinical studies 1. The human record is much shorter. One randomised trial shows fisetin lowering two inflammation markers 2, and the Mayo Clinic trials testing it against frailty in older adults have not yet produced published proof that it clears senescent cells in people 5.

What is fisetin?

Fisetin (chemical name 3,3',4',7-tetrahydroxyflavone) is a flavonol, one of the colour compounds plants make, and a close chemical cousin of quercetin. It sits in strawberries, apples, persimmons and onions, and it is sold in the US as a dietary supplement. That status matters: under US supplement law, a product like fisetin does not need FDA approval and is not checked for effectiveness before it reaches the shelf. Our guide to how supplements are regulated covers what that does and does not guarantee. As a food-derived flavonol, fisetin is not an approved drug for any condition, and it does not appear on the World Anti-Doping Agency's prohibited list.

Most fisetin interest comes from longevity research, where it belongs to a class called senolytics. The rest of this page separates what fisetin does in cells and preclinical studies from what it has done in people, because the two are far apart.

What does a senolytic do?

A senescent cell is a cell that has stopped dividing after damage but refuses to die. Researchers sometimes call them zombie cells. Cellular senescence is one of the recognised hallmarks of aging, and senescent cells build up in many tissues with age. They release a mix of inflammatory signals called the SASP (senescence-associated secretory phenotype), which is one proposed driver of the low-grade, body-wide inflammation covered in our guide to chronic inflammation 3.

How a senolytic clears a senescent cell

1
Damage stops the cell dividing
DNA damage, oxidative stress or repeated division pushes a cell into senescence: it stays alive but no longer divides.
2
The cell survives and leaks inflammation
Senescent cells lean on internal survival pathways (the BCL-2 family of proteins) to dodge programmed death, and they keep secreting SASP signals into nearby tissue.
3
A senolytic switches off the survival pathway
Fisetin interferes with those survival pathways in some cell types, so the senescent cell undergoes apoptosis, the tidy programmed death the immune system cleans up.
4
New senescent cells return slowly
Senescent cells take weeks to build back up, which is why researchers test short, spaced pulses instead of daily dosing.
Senolytics remove senescent cells that already exist; they do not stop new ones forming. A senostatic, by contrast, quiets the SASP without killing the cell 3.

Two limits matter. Fisetin's effect is cell-type specific: in lab work by Zhu and colleagues at the Mayo Clinic in 2017, it cleared senescent blood-vessel lining cells but not senescent fibroblasts or fat precursor cells. And clearing senescent cells is not always helpful, since they also play a short-term part in wound healing.

Fisetin benefits: preclinical results and human trials

The single distinction that decides how to read fisetin claims: almost every benefit listed online comes from cells or preclinical models, while the only published human outcome is a drop in two blood inflammation markers. A senolytic effect in people, meaning fewer senescent cells in human tissue, has not yet been shown for fisetin.

Fisetin is a senotherapeutic that extends health and lifespan.Title of Yousefzadeh and colleagues, EBioMedicine, 2018, a preclinical study

That 2018 paper is the root of most fisetin enthusiasm 1. Given late in life, fisetin lowered markers of senescence across several tissues and lengthened both median and maximum lifespan in aged preclinical models. A 2024 study from the University of Colorado found intermittent fisetin improved artery function in aged preclinical models by reducing senescent cells in the vessel wall 4. Earlier brain research reported that oral fisetin prevented learning and memory problems in a preclinical model of Alzheimer's disease, but there are no human trials of fisetin for memory or cognition.

In people, the clearest result is a 2018 randomised, placebo-controlled trial in colorectal cancer patients receiving chemotherapy. Taking 100 mg of fisetin a day for 7 weeks lowered IL-8 and hs-CRP compared with placebo 2. hs-CRP (high-sensitivity C-reactive protein) is a liver protein that rises with inflammation; IL-8 is an inflammatory signalling molecule. The trial was small, in a specific patient group, and did not measure senescent cells or aging.

The trials built to test the senolytic idea in people come from the Mayo Clinic. AFFIRM-LITE enrolled older women and gave fisetin at 20 mg/kg a day on two consecutive days, with frailty, inflammation and blood markers of senescence as the outcomes 5. A companion trial, AFFIRM (NCT03430037), tested the same kind of pulse in older adults. Until trials like these publish results showing benefit, the human case for fisetin as a senolytic rests on preclinical data plus one inflammation-marker trial.

ClaimBest evidenceShown in people?Strength
Kills senescent cellsFlavonoid screen and tissue markers, 2018 1NoPreclinical only
Extends lifespanLate-life dosing, 2018 1NoPreclinical only
Better artery functionIntermittent dosing, 2024 4NoPreclinical only
Protects memoryAlzheimer's model, 2014NoPreclinical only
Lowers inflammation markersRCT, 100 mg/day for 7 weeks 2Yes, one small trialEarly
Reduces frailty in older adultsMayo AFFIRM-LITE trial 5Under studyNone yet
Antioxidant, sirtuin and AMPK effectsCell and preclinical workNoPreclinical only

A 2022 review by the Mayo Clinic senescence group put the field's status plainly: senolytics are still at the clinical-trial stage, and none has yet been shown to extend human healthspan or lifespan 3. Our longevity hub tracks where other longevity compounds sit on the same scale.

Fisetin vs quercetin, and dasatinib plus quercetin

Fisetin and quercetin are sister flavonols, and both show up in senolytic research. In the 2018 screen, fisetin was the stronger senolytic of the two on its own 1. Quercetin's senolytic record comes mostly from pairing it with dasatinib, a prescription cancer drug. That pair, called D+Q, holds the only direct human evidence of senescent-cell clearance: 3 days of dasatinib plus quercetin reduced senescent cells in fat tissue biopsies from people with diabetic kidney disease 7.

Senolytics decrease senescent cells in humans.Title of Hickson and colleagues, EBioMedicine, 2019, the dasatinib plus quercetin trial

FisetinQuercetinDasatinib plus quercetin (D+Q)
TypeSupplement flavonolSupplement flavonolPrescription drug plus supplement
Senolytic strength aloneStrongest flavonoid in the 2018 screen 1Weaker aloneStrong as a pair
Human senescent-cell clearanceNot yet shownNot shown aloneShown in a small trial 7
Who controls accessOver the counterOver the counterDasatinib needs a prescriber

So which is better depends on the question. For senolytic potency in the lab, fisetin leads. For proof in human tissue, only D+Q has it, and dasatinib carries real drug side effects. The quercetin page covers that compound's own evidence.

Can you get enough fisetin from food?

Strawberries are by far the richest common source at about 160 micrograms per gram, with apples a distant second at about 27 6. A 150 g cup of strawberries therefore carries roughly 24 mg of fisetin (160 micrograms times 150 grams is 24,000 micrograms). Some popular articles state a cup holds 0.16 mg; that figure confuses micrograms per gram with a whole serving and is about 150 times too low. In the Japanese women Arai and colleagues studied, average daily intake was about 0.4 mg 6.

FoodFisetin (mcg per g)Typical servingFisetin per serving
Strawberriesabout 1601 cup, 150 gabout 24 mg
Appleabout 271 medium, 180 gabout 4.9 mg
Persimmonabout 111 fruit, 170 gabout 1.9 mg
Lotus rootabout 6100 gabout 0.6 mg
Onionabout 5100 gabout 0.5 mg
Grapesabout 41 cup, 150 gabout 0.6 mg
Kiwiabout 21 fruit, 75 gabout 0.15 mg

Content per gram from Arai and colleagues, 2000 6; serving weights are typical US portions, and real fruit varies with variety and ripeness. A strawberry-heavy day reaches tens of milligrams, well short of the doses used in trials, though the fruit brings fibre and other polyphenols that supplements do not.

Fisetin dosage: what the research used

No official dose exists for fisetin, because it is not approved for any use. The figures below describe what researchers gave in studies. They are research regimens, chosen for trial questions, and not a recommendation for anyone to copy.

RegimenAmount for a 70 kg adultWhere it comes fromEvidence in people
Steady low dose100 mg a day for 7 weeksColorectal cancer RCT 2Lower hs-CRP and IL-8
Intermittent high dose20 mg/kg a day on 2 consecutive days, about 1,400 mg a dayMayo AFFIRM-LITE and AFFIRM trials 5No published benefit so far
Preclinical pulse dose, converted100 mg/kg becomes about 8 mg/kg, about 570 mgBody-surface-area conversion of the short pulses in the 2018 study 1None
Typical supplement labels100 to 500 mg per capsuleProduct labelsNone for these amounts

The Mayo regimen is called hit-and-run dosing: a large amount on two consecutive days, then nothing. The logic is that senescent cells take weeks to build back up after they are cleared, so a short pulse may be enough and continuous exposure is not needed 3. That idea comes from preclinical work and is still being tested in people.

How to take it: forms, food and timing

Fisetin dissolves poorly in water, and the body works on it fast. After an oral dose it is quickly converted into sulfate and glucuronide forms and, in preclinical studies, partly into geraldol, a methylated version that is itself active. Plain fisetin powder therefore reaches the blood in small amounts. A randomised crossover study in healthy adults found that a hybrid-hydrogel formulation (fisetin bound with fenugreek fibre) gave about 26 times more fisetin in the blood than plain fisetin 8. Liposomal versions are also sold, with far less published data.

How fisetin is usually taken

With foodWith a meal that contains some fat, since fisetin dissolves poorly in water
How oftenStudies used either daily intake or two-day pulses; no schedule is established
No human trial has compared fasting with fed intake. Taking a flavonol with food is a reasonable inference from how poorly it dissolves, and enhanced formulations are the only forms with human absorption data 8. Look for third-party testing (USP or NSF marks), since supplement content can vary.

Fisetin side effects and who should skip it

Short trials report fisetin as well tolerated 2 8. Long-term safety in people is unknown, because no trial has followed users for years. Flavonols in lab studies can change how liver enzymes process some medicines and how platelets clump; whether fisetin does this at supplement doses in people has not been tested, so any interaction risk is unmeasured, which is different from absent.

Supplements can also shift lab results. Our guide to supplements that affect blood tests explains why to tell the person ordering your bloodwork what you take.

How would you know if fisetin is doing anything?

No routine blood test measures senescent cells, so nobody can check directly whether fisetin cleared any. What people can watch is the picture around it. hs-CRP is the marker the human trial moved 2, and our inflammation markers guide explains how to read it next to the others; the hs-CRP vs CRP comparison explains why the high-sensitivity version is the one to compare. Fasting insulin, glucose and HbA1c show the metabolic side. ALT (a liver enzyme) and eGFR (an estimate of kidney filtering) serve as a safety baseline, since the high-dose research pulses were run with that kind of bloodwork.

CalculatorHOMA-IR calculatorTurns fasting glucose and fasting insulin into one insulin-resistance number you can track over months.Work it out

One reading tells you little. hs-CRP jumps for days after a cold, a hard workout or a dental problem, so a single low result after starting fisetin proves nothing. A result from before starting and another a few months later, under similar conditions, gives a fairer comparison, and our piece on why trends beat single readings shows how much one marker can wander. Any result flagged abnormal belongs with your clinician, whatever you are taking.

Free, no accountRead your blood testHave bloodwork from before and after starting a supplement? Read every line of both, free.Read my results

No study has tested fisetin combined with resveratrol, nicotinamide riboside or other longevity supplements, so stacking them adds unknowns on top of unknowns. For another compound at the same early stage of human research, see humanin.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. Yousefzadeh MJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine, 2018;36:18-28
  2. Farsad-Naeimi A et al. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food & Function, 2018;9(4):2025-2031
  3. Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nature Medicine, 2022;28(8):1556-1568
  4. Mahoney SA et al. Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. Aging Cell, 2024;23(3):e14060
  5. AFFIRM-LITE: Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (NCT03675724). ClinicalTrials.gov, Mayo Clinic
  6. Arai Y et al. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. Journal of Nutrition, 2000;130(9):2243-2250
  7. Hickson LJ et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine, 2019;47:446-456
  8. Krishnakumar IM et al. Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals. Journal of Nutritional Science, 2022;11:e74

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.